These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27559190)

  • 21. Results of Leveraging Pharmaceutical Patient Assistance Programs to Expand Access to High Cost Medications in a Student-Run Free Clinic.
    Lee JJ; Sack DE; Kam S; Reed SC; Carew B; Lloyd C; Weaver EO; Miller RF
    J Community Health; 2023 Dec; 48(6):919-925. PubMed ID: 37284916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outpatient medication assistance program in a rural setting.
    Harmon GN; Lefante J; Roy W; Ashby KH; Jackson D; Barnard D; Smart A; Webber L
    Am J Health Syst Pharm; 2004 Mar; 61(6):603-7. PubMed ID: 15061432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic impact of ambulatory care formulary restrictions at a large county health system.
    Centeno A; Price V; Robinson N; Tomecko GW; Sedam B
    Am J Health Syst Pharm; 2013 Jul; 70(14):1238-43. PubMed ID: 23820461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical assistance programs for cancer patients in the era of orally administered chemotherapeutics.
    Mitchell A; Muluneh B; Patel R; Basch E
    J Oncol Pharm Pract; 2018 Sep; 24(6):424-432. PubMed ID: 28714357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlling Pharmaceutical Costs in a Student-Run Free Clinic in a Resource-Limited Patient Setting.
    He C; Kalagara R; Chennareddy S; Rodriguez N; Vahanan M; Mohammad A; Skovran D; Meah Y
    J Community Health; 2023 Dec; 48(6):913-918. PubMed ID: 37405614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilizing clinical pharmacists and a medication assistance program to improve medication access for indigent and underserved patients in primary care.
    Pickett B; Shin TR; Norton M
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100211. PubMed ID: 36582998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of medication-assistance programs for medically uninsured patients: one public teaching hospital's experience.
    Viale PH; Mister S
    Clin J Oncol Nurs; 2001; 5(6):247-52. PubMed ID: 11899624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demystifying pharmaceutical patient assistance programs.
    Collier EK; Price KN; Hsiao JL; Shi VY
    J Dermatolog Treat; 2022 Feb; 33(1):336-341. PubMed ID: 32308069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective study of direct cost to patients associated with the use of oral oncology medications for the treatment of multiple myeloma.
    Lee C; Grigorian M; Nolan R; Binder G; Rice G
    J Med Econ; 2016; 19(4):397-402. PubMed ID: 26652728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a community pharmacy human papillomavirus vaccine program for underinsured university students along the United States/Mexico border.
    Navarrete JP; Padilla ME; Castro LP; Rivera JO
    J Am Pharm Assoc (2003); 2014; 54(6):642-7. PubMed ID: 25343721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Patient Assistance Programs on Hospital Visits in Patients With Chronic Obstructive Pulmonary Disease or Asthma.
    Gallman BN; Huddleston JW; Ray ME; Smith SE
    J Pharm Pract; 2023 Oct; 36(5):1113-1117. PubMed ID: 35428409
    [No Abstract]   [Full Text] [Related]  

  • 33. The impact of patient assistance programs and the 340B Drug Pricing Program on medication cost.
    Castellon YM; Bazargan-Hejazi S; Masatsugu M; Contreras R
    Am J Manag Care; 2014 Feb; 20(2):146-50. PubMed ID: 24738532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic implications of evidence-based prescribing for hypertension: can better care cost less?
    Fischer MA; Avorn J
    JAMA; 2004 Apr; 291(15):1850-6. PubMed ID: 15100203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assistance programs available for medications commonly used in transplant patients.
    Chisholm MA; Tackett KL; Kendrick BD; DiPiro JT
    Clin Transplant; 2000 Aug; 14(4 Pt 1):269-81. PubMed ID: 10945196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of obtaining medications from pharmaceutical company assistance programs on therapeutic goals.
    Trompeter JM; Havrda DE
    Ann Pharmacother; 2009 Mar; 43(3):469-77. PubMed ID: 19240259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient participation in a clinic-based community pharmacy medication take-back program.
    Lystlund S; Stevens E; Planas LG; Marcy TR
    J Am Pharm Assoc (2003); 2014; 54(3):280-4. PubMed ID: 24816355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Recovery and Copay Assistance Program in a Community Cancer Center: Charity and Challenges.
    Siegel RD; Slough RG; Crosswell HE; Standifer TM; Borron ME; Pringle DL; Hancock KK; Widener LH; Hill EB; Spann TF; Stoeppler-Biege KM
    J Oncol Pract; 2019 Jul; 15(7):e628-e635. PubMed ID: 31162998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Operation Donate: defining the value of redispensing medications donated by individuals.
    Glanville M; Brady R; Miller S
    J Am Pharm Assoc (2003); 2014; 54(5):542-7. PubMed ID: 25216885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.